PodcastIntel
Sign in Get Started Free
How I Invest w/David Weisburd

Why Biotech Is Struggling in Today’s Market (and the Future of Healthcare)

Apr 22, 2026 · 0:31:26
AI Summary
  • David Berry sees healthcare innovation in system reinvention, not just new drugs.
  • Biotech faces challenges from pricing pressure and rising costs.
  • AI, data, and new business models are the future of healthcare.

More from How I Invest w/David Weisburd

View all episodes →

Get AI Summaries for Every New Episode

Subscribe to How I Invest w/David Weisburd and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →